Japan Knee Hyaluronic Acid Injection Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Single Injection, Three Injections, and Five Injections), By Application (Osteoarthritis, Rheumatoid Arthritis, and Others), and Japan Knee Hyaluronic Acid Injection Market Insights, Industry Trend, Forecasts to 2033.

Industry: Healthcare

RELEASE DATE Mar 2025
REPORT ID SI9186
PAGES 210
REPORT FORMAT PathSoft

Japan Knee Hyaluronic Acid Injection Market Insights Forecasts to 2033

  • The Japan Knee Hyaluronic Acid Injection Market Size was valued at USD 158.14 Million in 2023
  • The Market is Growing at a CAGR of 8.19% from 2023 to 2033
  • The Japan Knee Hyaluronic Acid Injection Market Size is Expected to Reach USD 278.11 Million by 2033

Japan Knee Hyaluronic Acid Injection Market

Get more details on this report -

Request Free Sample PDF

The Japan Knee Hyaluronic Acid Injection Market is Anticipated to Reach USD 278.11 Million by 2033, growing at a CAGR of 8.19% from 2023 to 2033.

 

Market Overview

The Japan Knee hyaluronic acid injection market is the industry focused on the creation, manufacturing, and marketing of hyaluronic acid injections intended especially for the treatment of knee joints. The market for knee hyaluronic acid injections is expanding as a result of technological developments and advances in Japan's pharmaceutical and medical device sectors. To improve the efficacy and safety profiles of hyaluronic acid injections, novel formulations and delivery systems are being explored in Japan. For example, single-injection therapies have greatly simplified the procedure and decreased the number of visits needed by Japanese patients. This development not only increases patient compliance but also reduces healthcare expenses in Japan as a whole, which promotes domestic market growth.

 

Report Coverage

This research report categorizes the market for the Japan knee hyaluronic acid injection market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan knee hyaluronic acid injection market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan knee hyaluronic acid injection market.

 

Japan Knee Hyaluronic Acid Injection Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 158.14 Million
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :8.19%
2033 Value Projection:USD 278.11 Million
Historical Data for:2019-2022
No. of Pages:210
Tables, Charts & Figures:115
Segments covered:By Product Type, By Application and COVID-19 Impact Analysis
Companies covered:: Seikagaku Corporation, Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Mochida Pharmaceutical Co., Ltd., and Other Key Players
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The market for Japan knee hyaluronic acid injection is driven by one major factor which is the increasing prevalence of knee-related problems such as knee osteoarthritis and other forms of arthritis, these rising knee problems within Japanese people further boost the requirement for knee hyaluronic acid injection in Japan. Additionally, as Japanese patients increasingly prefer less invasive methods for alleviating knee pain, the need for hyaluronic acid injections continues to grow significantly. Furthermore, around 70% of people in Japan had pain at one or more joints; knee discomfort ranged from 36% of people aged 60–69 to 53% of people aged 70–79 (mean 41%). The market for Japan's knee hyaluronic acid injections is expanding because of the country's high incidence of knee pain, especially among its elderly population. These injections are becoming a more and more popular option for treating knee-related problems in the nation since they provide a minimally intrusive way to manage pain and enhance joint function.

 

Restraining Factors

The high expense of treatment is one of the main obstacles. Injections of hyaluronic acid can be costly, and in certain areas, insurance may not pay the entire cost. Patients' access to treatment may be restricted as a result, especially in low- and middle-income nations.

 

Market Segmentation

The Japan knee hyaluronic acid injection market share is classified into product type and application.

  • The single injection segment is expected to hold a significant market share through the forecast period.

The Japan knee hyaluronic acid injection market is segmented by product type into single injection, three injections, and five injections. Among these, the single injection segment is expected to hold a significant market share through the forecast period. The convenience and decreased treatment load for patients have been major factors in the recent surge in popularity of the single injection market. Long-lasting pain and inflammation alleviation is possible with single injections, which deliver a large amount of hyaluronic acid all at once.

 

  • The osteoarthritis segment is expected to hold a significant market share through the forecast period.

The Japan knee hyaluronic acid injection market is segmented by application into osteoarthritis, rheumatoid arthritis, and others. Among these, the osteoarthritis segment is expected to hold a significant market share through the forecast period. Millions of individuals in Japan suffer from this chronic joint disease, especially the elderly. It is generally known that hyaluronic acid injections for osteoarthritis significantly reduce pain and enhance joint function.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan knee hyaluronic acid injection market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Seikagaku Corporation
  • Eisai Co., Ltd.
  • Chugai Pharmaceutical Co., Ltd.
  • Ono Pharmaceutical Co., Ltd.
  • Kaken Pharmaceutical Co., Ltd.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Mochida Pharmaceutical Co., Ltd.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Knee Hyaluronic Acid Injection Market based on the below-mentioned segments

 

Japan Knee Hyaluronic Acid Injection Market, By Product Type

  • Single Injection
  • Three Injections
  • Five Injections

 

Japan Knee Hyaluronic Acid Injection Market, By Application  

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies